Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

1477.HK Net Margin

The Net Margin of Ocumension Therapeutics (1477.HK) is -64.29%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

1477.HK Net Margin - Historical Value
Date Value
2024-12-31 -64.29%
2023-12-31 -154.15%
2022-12-31 -253.30%
2021-12-31 -463.06%
2020-12-31 -17294.33%
2019-12-31 -690690.00%
2018-12-31 -690690.00%
1477.HK Net Margin - Peers Comparison
Ticker Name Value
300705.SZ Hunan Jiudian Pharmaceutical Co Ltd 17.48%
603229.SS Zhejiang Ausun Pharmaceutical Co Ltd 31.09%
688513.SS Chengdu Easton Biopharmaceuticals Co Ltd 20.28%
002275.SZ Guilin Sanjin Pharmaceutical Co Ltd 23.77%
300765.SZ CSPC Innovation Pharmaceutical Co Ltd 2.71%
603439.SS Guizhou Sanli Pharmaceutical Co Ltd 17.90%
603520.SS Zhejiang Starry Pharmaceutical Co Ltd 2.01%
688356.SS Jenkem Technology Co Ltd 39.62%
300630.SZ Hainan Poly Pharm Co Ltd 6.59%
603718.SS Shanghai Hile Bio-Technology Co Ltd 63.16%
688189.SS Hunan Nucien Pharmaceutical Co Ltd 0.50%
002287.SZ Tibet Cheezheng Tibetan Medicine Co Ltd 24.91%
300119.SZ Tianjin Ringpu Bio-Technology Co Ltd 9.80%
300497.SZ Jiangxi Fushine Pharmaceutical Co Ltd -12.47%
300573.SZ Shenyang Xingqi Pharmaceutical Co Ltd 17.40%
688505.SS Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 5.60%
688526.SS Wuhan Keqian Biology Co Ltd 40.59%
300401.SZ Zhejiang Garden Biopharmaceutical Co Ltd 24.87%
600851.SS Shanghai Haixin Group Co Ltd 18.97%
605199.SS Hainan Huluwa Pharmaceutical Group Co Ltd -19.42%
300436.SZ Fujian Cosunter Pharmaceutical Co Ltd -35.41%
603566.SS Pulike Biological Engineering Inc 8.90%
603590.SS Beijing Konruns Pharmaceutical Co Ltd 16.35%
688321.SS Shenzhen Chipscreen Biosciences Co Ltd -17.41%
002099.SZ Zhejiang Hisoar Pharmaceutical Co Ltd -17.04%
300723.SZ ApicHope Pharmaceutical Co Ltd -37.24%
688098.SS Shanghai Shen Lian Biomedical Corp 10.45%
605116.SS Aurisco Pharmaceutical Co Ltd 22.92%